Global Finance Invests in the Turkish Pharmaceutical Producer BIOFARMA

Global Finance through its latest buy-out fund, the South Eastern European Fund, is pleased to announce its participation in the share capital of Biofarma, among the largest generic pharmaceutical producers in Turkey. Biofarma was recently acquired by Partners in Life Sciences (PiLS) and Citigroup Venture Capital International (CVCI).

“We strongly believe in the growth prospects of the generic pharmaceutical market of the region and of Biofarma and are happy to join two very strong and prestigious investors such as PiLS and CVCI. Global Finance had stellar returns in the pharmaceutical sector with Sicomed, among the largest pharmaceutical companies in Romania and feels it can add value to this deal both through its solid sector knowledge as well as through its strong regional presence”, a spokesperson from Global Finance said.

Global Finance is an independent investment firm. Founded in 1991, it pioneered private equity in South-Eastern Europe and has established an exceptional investment track record. Today it manages over €700m in funds targeting private equity and real estate investments in South-Eastern Europe.

Well yet everyone be aware of that found with ease in the Internet. In particular on our website it is full of it. But you forget and constantly you ask.